Breast Cancer Patients Without Pain Are at Risk for Skeletal-Related Events (Sres) and May Have Better Outcomes with Zoledronic Acid Compared with Pamidronate
30Th Congress of the European-Society-For-Medical-Oncology, Date: SEP 29-OCT 03, 2006, Location: Istanbul, TURKEY, Patrocinadores: European Soc Med Oncol
